journal article·2024-08-01Open access

Comparative Study on the Responsiveness of Different Species to Coagulation and Complement for Hemocompatibility Evaluation

Jeonghwa Kim, Geonyong Kim, Jiyoung Lim, Sekyung Kim, Joonho Eom, Taewon Kim

Applied Sciences· Volume 14· Issue 15

Abstract

Background: According to the International Standard (ISO10993-4), a test model using human blood must be used for blood compatibility evaluation of medical devices. However, various safety investigations have reported outcomes from animal models simulating clinical conditions. Additionally, the validation of animal blood in blood compatibility assessment models is limited. In this study, the differences in the reactivity of different species to coagulation and complement, as well as the main mechanisms governing blood clot formation upon contact with medical devices, were examined. Moreover, it aimed to acquire information required to design a hemocompatibility evaluation model and interpret the results. Results: Rabbits, porcine, rhesus monkeys, and cynomolgus monkeys were exposed to one negative and two positive control substances, and variations in the partial thromboplastin time (PTT) were observed. The activity of the complement system was observed in accordance with the test method in ISO 10993-4. Although the PTT absolute values varied across animal species, the normalized PTT values—61% for rabbits, 66% for pigs, 63% for rhesus monkeys, and 65% for cynomolgus monkeys—exhibited no statistically significant differences. After reacting human and porcine sera with the material, the test model using human serum distinguished the positive and negative control candidates, whereas the test model using porcine serum could not discriminate them. Conclusions: These results suggest similar reactivity in blood coagulation across species after substance contact. However, complement system activity indicated a significant difference in reactivity between human and porcine blood. This finding will be useful in the design of a blood compatibility evaluation model for medical devices and interpretation of the results.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Complement system in diseases · Mechanical Circulatory Support Devices · Blood donation and transfusion practices

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Bio-Health Center (GLP), Korea Testing Certification Institute, Cheongju 28115, Republic of Korea

Department of Medical Device Research Division, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea

Funding

Ministry of Food and Drug Safety

References (32)

Show source-provided references
1. (2017). Biological Evaluation of Medical Devices—Part 4: Selection of Tests for Interactions with Blood (Standard No. ISO 10993-4).
2. (2019). Standard Practice for Platelet Leukocyte Count-An In-Vitro Measure for Hemocompatibility Assessment of Cardiovascular Materials (Standard No. ASTM F2888-19).
3. (2016). Cardiovascular Implants and Extracorporeal Systems—Vascular Prostheses—Tubular Vascular Grafts and Vascular Patches (Standard No. ISO 7198:2016).
4. (2016). Cardiovascular Implants and Artificial Organs—Blood-Gas Exchangers (Oxygenators) (Standard No. ISO 7199:2016).
5. Some species differences in fibrinolysis and blood coagulation10.1002/jbm.820050109 ↗
6. Blood-clotting mechanisms of nonhuman primates. Choice of the baboon model to simulate man10.1159/000460376 ↗
7. In-vitro study of species-specific coagulation differences in animals and humans using rotational thromboelastometry (ROTEM)10.1136/jramc-2018-001092 ↗
8. In vitro shear stress-induced platelet activation: Sensitivity of human and bovine blood10.1111/aor.12099 ↗
9. Shear stress-induced total blood trauma in multiple species10.1111/aor.12932 ↗
10. Sheep, pig, and human platelet-material interactions with model cardiovascular biomaterials10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.0.CO;2-C ↗
11. Adhesive properties of platelets from different animal species10.1053/jcpa.2002.0615 ↗
12. Interspecies differences in coagulation profile10.1160/TH08-02-0103 ↗
13. Species variability in platelet aggregation response to different agonists10.1053/jcpa.2002.0570 ↗
14. Comparison of porcine and human coagulation by thrombelastometry10.1016/j.thromres.2011.03.013 ↗
15. (2018). Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT) (Standard No. ASTM F2382-18).
16. (2021). Biological Evaluation of Medical Devices—Part 12: Sample Preparation and Reference Materials (Standard No. ISO 10993-12).
17. Roshal, M., and Gil, M.R. (2019). Activated Partial Thromboplastin Time. Transfusion Medicine and Hemostasis, Elsevier. [3rd ed.].10.1016/B978-0-12-813726-0.00129-X ↗
18. Contact activation of plasmatic coagulation on polymeric membranes measured by the activity of kallikrein in heparinized plasma10.1163/156856297X00326 ↗
19. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation10.1055/s-0037-1615025 ↗
20. Age-related changes of platelet and plasma coagulation parameters in young pigs10.1177/1040638716658928 ↗
21. Comparative aspects of blood coagulation10.1016/j.tvjl.2003.09.013 ↗
22. Hemostasis in massively transfused trauma patients10.1097/00000658-197907000-00020 ↗
23. Complement. First of two parts10.1056/NEJM200104053441406 ↗
24. Complement. Second of two parts10.1056/NEJM200104123441506 ↗
25. Advances in assay of complement function and activation10.1016/j.addr.2011.05.010 ↗
26. Deposition of complement activation products on plastic-adsorbed immunoglobulins. A simple ELISA technique for the detection of defined complement deficiencies10.1016/0022-1759(89)90193-2 ↗
27. Overview of complement activation and regulation10.1016/j.semnephrol.2013.08.001 ↗
28. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies10.1097/00007890-199508000-00014 ↗
29. Studies of Pig Complement: Measurement of Pig CH50, ACH50, and Components10.1016/j.transproceed.2015.10.066 ↗
30. Szebeni, J., and Bawa, R. (2020). Human clinical relevance of the porcine model of pseudoallergic infusion reactions. Biomedicines, 8.10.3390/biomedicines8040082 ↗
31. Quantitation of comparative thrombogenicity of dog, pig, and human platelets in a hemodialyzer
32. Didisheim, P., Dewanjee, M.K., Frisk, C.S., Kaye, M.P., and Fass, D.N. (1984). Animal models for predicting clinical performance of biomaterials for cardiovascular use. Contemporary Biomaterials: Material and Host Response, Clinical Applications, New Technology, and Legal Aspects, Noyes Publications.